---
title: "VIRAX BIOLABS (CAYMAN) LTD — Ownership Dossier"
canonical: https://whiteintel.dev/entity/f0c5bbab-9643-5ac1-a154-3804ef6f9fc3
json: https://whiteintel.dev/api/public/dossier/f0c5bbab-9643-5ac1-a154-3804ef6f9fc3
identifier: sec:0001885827
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# VIRAX BIOLABS (CAYMAN) LTD

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001885827`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/f0c5bbab-9643-5ac1-a154-3804ef6f9fc3  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/f0c5bbab-9643-5ac1-a154-3804ef6f9fc3  

## Ownership & control

### UBO chain (walk to the ultimate owner)

A **7-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **VIRAX BIOLABS (CAYMAN) LTD**. Human view: https://whiteintel.dev/entity/f0c5bbab-9643-5ac1-a154-3804ef6f9fc3 · Structured JSON: https://whiteintel.dev/api/public/dossier/f0c5bbab-9643-5ac1-a154-3804ef6f9fc3._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._